Warner Prevoo

2.6k total citations
48 papers, 1.1k citations indexed

About

Warner Prevoo is a scholar working on Pulmonary and Respiratory Medicine, Hepatology and Surgery. According to data from OpenAlex, Warner Prevoo has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 17 papers in Hepatology and 15 papers in Surgery. Recurrent topics in Warner Prevoo's work include Renal cell carcinoma treatment (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers) and Renal and related cancers (10 papers). Warner Prevoo is often cited by papers focused on Renal cell carcinoma treatment (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers) and Renal and related cancers (10 papers). Warner Prevoo collaborates with scholars based in Netherlands, United Kingdom and United States. Warner Prevoo's co-authors include Simon Horenblas, Axel Bex, Benno H. W. Hendriks, Jarich W. Spliethoff, Theo J. M. Ruers, Frits van Coevorden, Daniel J. Evers, Renato A. Valdés Olmos, Thomas M. van Gulik and Richard van Hillegersberg and has published in prestigious journals such as Cancer, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Warner Prevoo

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Warner Prevoo Netherlands 21 381 363 344 321 228 48 1.1k
Arantza Fariña Sarasqueta Netherlands 22 366 1.0× 182 0.5× 1.0k 3.0× 383 1.2× 147 0.6× 83 1.8k
Seza A. Güleç United States 20 375 1.0× 446 1.2× 403 1.2× 245 0.8× 541 2.4× 43 1.3k
Paxton V. Dickson United States 24 431 1.1× 250 0.7× 756 2.2× 835 2.6× 115 0.5× 101 2.0k
Zuxing Kan United States 22 196 0.5× 656 1.8× 144 0.4× 303 0.9× 276 1.2× 33 1.2k
Darren M.C. Poon Hong Kong 18 544 1.4× 141 0.4× 402 1.2× 383 1.2× 511 2.2× 91 1.5k
Marine Gilabert France 22 422 1.1× 485 1.3× 910 2.6× 276 0.9× 93 0.4× 73 1.8k
Xiaochun Meng China 18 262 0.7× 259 0.7× 425 1.2× 296 0.9× 648 2.8× 63 1.3k
Schlomo Schneebaum Israel 17 194 0.5× 70 0.2× 574 1.7× 232 0.7× 248 1.1× 54 1.1k
Jessica Spahn United States 17 260 0.7× 446 1.2× 503 1.5× 173 0.5× 32 0.1× 27 1.1k
Marc Van den Eynde Belgium 21 347 0.9× 260 0.7× 972 2.8× 331 1.0× 359 1.6× 90 1.6k

Countries citing papers authored by Warner Prevoo

Since Specialization
Citations

This map shows the geographic impact of Warner Prevoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warner Prevoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warner Prevoo more than expected).

Fields of papers citing papers by Warner Prevoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warner Prevoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warner Prevoo. The network helps show where Warner Prevoo may publish in the future.

Co-authorship network of co-authors of Warner Prevoo

This figure shows the co-authorship network connecting the top 25 collaborators of Warner Prevoo. A scholar is included among the top collaborators of Warner Prevoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warner Prevoo. Warner Prevoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smits, Maarten L. J., Rutger C. G. Bruijnen, Martijn R. Meijerink, et al.. (2023). Hepatic Arteriography and C-Arm CT-Guided Ablation (HepACAGA) to Improve Tumor Visualization, Navigation and Margin Confirmation in Percutaneous Liver Tumor Ablation. CardioVascular and Interventional Radiology. 46(10). 1365–1374. 10 indexed citations
2.
Prevoo, Warner, Mark A. Meier, Axel Bex, et al.. (2020). Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma. CardioVascular and Interventional Radiology. 43(7). 1025–1033. 24 indexed citations
3.
Zondervan, Patricia, Elisabeth G. Klompenhouwer, Otto M. van Delden, et al.. (2020). Renal biopsies performed before versus during ablation of T1 renal tumors: implications for prevention of overtreatment and follow-up. Abdominal Radiology. 46(1). 373–379. 17 indexed citations
4.
Kirstein, Martha M., Roland Brüning, M Zeile, et al.. (2018). Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival. European Radiology. 29(4). 1882–1892. 27 indexed citations
5.
Meijerink, Martijn R., Robbert S. Puijk, Aukje A. J. M. van Tilborg, et al.. (2018). Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. CardioVascular and Interventional Radiology. 41(8). 1189–1204. 145 indexed citations
6.
Spliethoff, Jarich W., Lisanne L. de Boer, Mark A. Meier, et al.. (2016). Spectral sensing for tissue diagnosis during lung biopsy procedures: The importance of an adequate internal reference and real-time feedback. Lung Cancer. 98. 62–68. 10 indexed citations
7.
Nijkamp, Jasper, et al.. (2016). Baseline tumor volume in assessing prognosis of patients with intermediate-risk synchronous metastatic renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 34(6). 258.e7–258.e13. 5 indexed citations
8.
Crusz, Shanthini Mary, Yen Zhi Tang, Shah‐Jalal Sarker, et al.. (2016). Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma. BMC Medicine. 14(1). 185–185. 28 indexed citations
9.
Tanis, E., Jarich W. Spliethoff, Daniel J. Evers, et al.. (2015). Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy. European Journal of Surgical Oncology. 42(2). 251–259. 38 indexed citations
10.
El‐Haddad, Ghassan, et al.. (2014). [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy. PET Clinics. 9(4). 469–495. 7 indexed citations
11.
Schellekens, Pascal P.A., Tjeerd S. Aukema, J. Joris Hage, Warner Prevoo, & Moshe Kon. (2013). Can Previous Diagnostic Examinations Prevent Preoperative Angiographic Assessment of the Internal Mammary Perforators for (Micro)Surgical Use?. Annals of Plastic Surgery. 72(5). 560–565. 5 indexed citations
12.
Meyenfeldt, Erik M. von, et al.. (2011). Local progression after radiofrequency ablation for pulmonary metastases. Cancer. 117(16). 3781–3787. 18 indexed citations
13.
Korse, Catharina M., Johannes M.G. Bonfrèr, Warner Prevoo, Paul Baas, & Babs G. Taal. (2011). Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours. Tumor Biology. 32(4). 647–652. 12 indexed citations
14.
Boone, J., Axel Bex, & Warner Prevoo. (2011). Percutaneous Radiofrequency Ablation of a Small Renal Mass Complicated by Appendiceal Perforation. CardioVascular and Interventional Radiology. 35(3). 695–699. 6 indexed citations
15.
Bex, Axel, et al.. (2010). Feasibility of sentinel node detection in renal cell carcinoma: a pilot study. European Journal of Nuclear Medicine and Molecular Imaging. 37(6). 1117–1123. 36 indexed citations
16.
Bex, Axel, Lenka Vermeeren, Wim Meinhardt, et al.. (2010). Intraoperative sentinel node identification and sampling in clinically node-negative renal cell carcinoma: initial experience in 20 patients. World Journal of Urology. 29(6). 793–799. 30 indexed citations
17.
Jansen, Maarten C., Sander Van Wanrooy, Richard van Hillegersberg, et al.. (2007). Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors. European Journal of Surgical Oncology. 34(6). 662–667. 29 indexed citations
18.
Kaas, R., Robert Kröger, Jan H. C. L. Hendriks, et al.. (2004). The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers. European Radiology. 14(9). 1647–53. 32 indexed citations
19.
Mutsaerts, Eduard L.A.R., Frits van Coevorden, Raymond J. Krause, et al.. (2003). Initial experience with radiofrequency ablation for hepatic tumours in the Netherlands. European Journal of Surgical Oncology. 29(9). 731–734. 15 indexed citations
20.
Berends, Frits J., S. Meijer, Warner Prevoo, H. J. Bonjer, & Miguel A. Cuesta. (2001). Technical considerations in laparoscopic liver surgery. Surgical Endoscopy. 15(8). 794–798. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026